Meletios Therapeutics aim is to fulfill the urgent and large unmet medical need for antiviral molecules against current and emerging diseases.

As far back as we can remember, there has always been a real concern for human communities about epidemics which have been incredibly devastating in the past. And we are nowadays seeing a speeding up of the phenomenon. We are increasingly interconnected and pushing the boundaries of our environment further and further, yielding unknown viruses to come out into the open.

There is thus a real need to anticipate the emergence of new viruses that could lead to globalized epidemics such as COVID-19.

To tackle future emerging viruses, we need to implement everything possible to channel the epidemics. Vaccines and treatments are 2 complementary therapeutic strategies.

Vaccines are a key preventive tool but have the disadvantage of targeting a virus that needs to be already (well) known and are uncertain against possible variants. It can also take a long time to implement them.

An alternative is therefore needed for patients already ill to treat their symptoms and resolve the infection from the start of the epidemic. Depending on their mechanism of action, antiviral drugs can be effective against a wide range of viruses and are therefore an important hope for limiting the impact of pandemics.